269 related articles for article (PubMed ID: 10946277)
21. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
[TBL] [Abstract][Full Text] [Related]
22. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W
J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357
[TBL] [Abstract][Full Text] [Related]
23. Self-association of CIITA and its transactivation potential.
Sisk TJ; Roys S; Chang CH
Mol Cell Biol; 2001 Aug; 21(15):4919-28. PubMed ID: 11438649
[TBL] [Abstract][Full Text] [Related]
24. Suppression of Il-12 transcription in macrophages following Fc gamma receptor ligation.
Grazia Cappiello M; Sutterwala FS; Trinchieri G; Mosser DM; Ma X
J Immunol; 2001 Apr; 166(7):4498-506. PubMed ID: 11254706
[TBL] [Abstract][Full Text] [Related]
25. Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes.
Otten LA; Tacchini-Cottier F; Lohoff M; Annunziato F; Cosmi L; Scarpellino L; Louis J; Steimle V; Reith W; Acha-Orbea H
J Immunol; 2003 Feb; 170(3):1150-7. PubMed ID: 12538670
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the human P450scc gene by steroidogenic factor 1 is mediated by CBP/p300.
Monté D; DeWitte F; Hum DW
J Biol Chem; 1998 Feb; 273(8):4585-91. PubMed ID: 9468515
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.
Tosi G; Pilotti E; Mortara L; De Lerma Barbaro A; Casoli C; Accolla RS
Proc Natl Acad Sci U S A; 2006 Aug; 103(34):12861-6. PubMed ID: 16908858
[TBL] [Abstract][Full Text] [Related]
28. Class II major histocompatibility complex transactivator (CIITA) inhibits matrix metalloproteinase-9 gene expression.
Nozell S; Ma Z; Wilson C; Shah R; Benveniste EN
J Biol Chem; 2004 Sep; 279(37):38577-89. PubMed ID: 15247301
[TBL] [Abstract][Full Text] [Related]
29. p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter.
Jayaraman G; Srinivas R; Duggan C; Ferreira E; Swaminathan S; Somasundaram K; Williams J; Hauser C; Kurkinen M; Dhar R; Weitzman S; Buttice G; Thimmapaya B
J Biol Chem; 1999 Jun; 274(24):17342-52. PubMed ID: 10358095
[TBL] [Abstract][Full Text] [Related]
30. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
[TBL] [Abstract][Full Text] [Related]
31. Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes.
Kanazawa S; Peterlin BM
Int Immunol; 2001 Jul; 13(7):951-8. PubMed ID: 11431425
[TBL] [Abstract][Full Text] [Related]
32. Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.
Beaulieu YB; Leon Machado JA; Ethier S; Gaudreau L; Steimle V
PLoS One; 2016; 11(2):e0148753. PubMed ID: 26871568
[TBL] [Abstract][Full Text] [Related]
33. Angiotensinogen gene expression is dependent on signal transducer and activator of transcription 3-mediated p300/cAMP response element binding protein-binding protein coactivator recruitment and histone acetyltransferase activity.
Ray S; Sherman CT; Lu M; Brasier AR
Mol Endocrinol; 2002 Apr; 16(4):824-36. PubMed ID: 11923478
[TBL] [Abstract][Full Text] [Related]
34. Synergistic activation of the germline epsilon promoter mediated by Stat6 and C/EBP beta.
Mikita T; Kurama M; Schindler U
J Immunol; 1998 Aug; 161(4):1822-8. PubMed ID: 9712049
[TBL] [Abstract][Full Text] [Related]
35. Repression of IFN-gamma induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling.
Tooze RM; Stephenson S; Doody GM
J Immunol; 2006 Oct; 177(7):4584-93. PubMed ID: 16982896
[TBL] [Abstract][Full Text] [Related]
36. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.
Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W
Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673
[TBL] [Abstract][Full Text] [Related]
37. Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA is essential for CIITA stability and MHC class II expression.
Bhat KP; Truax AD; Brooks JK; Greer SF
Immunol Cell Biol; 2010; 88(8):807-16. PubMed ID: 20351748
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of p300/CBP by early B-cell factor.
Zhao F; McCarrick-Walmsley R; Akerblad P; Sigvardsson M; Kadesch T
Mol Cell Biol; 2003 Jun; 23(11):3837-46. PubMed ID: 12748286
[TBL] [Abstract][Full Text] [Related]
39. Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators.
Deng WG; Zhu Y; Wu KK
Blood; 2004 Mar; 103(6):2135-42. PubMed ID: 14630807
[TBL] [Abstract][Full Text] [Related]
40. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
